Travoprost 0.004% Eye prep
Aphakic patient, pseudophakic patient w/ torn posterior lens capsule or anterior chamber lenses, or w/ known risk factor for cystoid macular oedema. Patient w/ history of intraocular inflammation (e.g. uveitis, iritis). Pregnancy and lactation. Patient Counselling Remove contact lenses prior to admin and reinsert after 15 min. Lactation: distributed in milk in animals; caution if used in nursing women
Ocular hypertension, Open-angle glaucoma
Hypersensitivity, Pregnancy
N/A
>10% Increased pigmentation of iris & periorbital tissue & increased pigmentation, thickening, elongation & growth of eyelashes (59%),Ocular hyperemia (35-50%) 1-10% Decreased visual acuity (5-10%),Ocular discomfort (5-10%),Foreign body sensation (5-10%),Pain (5-10%),Pruritus (5-10%),Abnormal vision (1-4%),Blepharitis (1-4%),Blurred vision (1-4%),Cataract (1-4%),Conjunctivitis (1-4%),Dry eye (1-4%),Iris discoloration (1-4%),Keratitis (1-4%),Lid margin crusting (1-4%),Photophobia (1-4%),Subconjunctival hemorrhage (1-4%),Tearing (1-4%)
Travoprost, a synthetic analogue of prostaglandin F2α, reduces intraocular pressure by increasing uveoscleral outflow of aqueous humour.
Reduced therapeutic effect w/ NSAIDs.
Pregnancy Category: C Lactation: distributed in milk in animals; caution if used in nursing women
Ophthalmic Ocular hypertension; Open-angle glaucoma Adult: As 0.004% soln: Instill 1 drop in the conjunctival sac of the affected eye(s) once daily, preferably in the evening.
Safety and efficacy not established
N/A
N/A
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.